Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference25 articles.
1. Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development;Eriksson;Clin Pharmacokinet,2009
2. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011
3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009
4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011
5. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration;Liberati;PLoS Med,2009
Cited by 368 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Longitudinal Analysis of Risk Factors and Outcomes in Patients with Atrial Fibrillation: Stroke and Bleeding Events;Journal of Pharmacy and Bioallied Sciences;2024-07-01
2. Management of Cardiovascular Disease in the Elderly;Geriatric Medicine;2024
3. Reshaping Anticoagulation: Factor XI Inhibition in Thrombosis Management;Hämostaseologie;2023-12-20
4. Direct oral anti-Xa anticoagulants versus warfarin in newly diagnosed atrial fibrillation and CKD: the Korean National Health Insurance Data;Frontiers in Medicine;2023-09-15
5. Full Reversal of Anticoagulants Before Cephalomedullary Fixation of Geriatric Hip Fractures May Not Be Necessary;Journal of Orthopaedic Trauma;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3